| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1375553 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Abstract
Both synthesis and activity of the novel derivatives of (1,2,3-triazol-4-yl)benzenamines are described. Selected molecules of these series are potent and selective inhibitors of vascular endothelial growth factor receptors I and II (VEGFR-1/2).
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Alexander S. Kiselyov, Marina Semenova, Victor V. Semenov,